bit.bio featured as one of Europe's fastest-growing startups in Sifted.
bit.bio featured as one of Europe's fastest-growing startups in Sifted.
bit.bio featured as one of Europe's fastest-growing startups in Sifted.
bit.bio featured as one of Europe's fastest-growing startups in Sifted.
bit.bio's CEO, envisions a new era of cell therapies, where cells themselves become intelligent drugs, precisely tailored to indiv...
bit.bio's CEO, our cell programming approach and our products prominently covered in synthetic biology article.
Editor-in-Chief Carlos-Filipe Pereira interviews our CEO for the Reprogramming Stars series in the journal Cellular Reprogramming.
Endpoints News did an exclusive interview with bit.bio's CEO after the cell therapy pipeline announcement with an initial focus on...
WIRED have named 16 Trailblazer companies in Cambridge that are pushing boundaries and scaling up - including bit.bio.
Authority Magazine interviewed bit.bio's SVP of tech ops and manufacturing Kathryn Golden to discover her path to leadership and w...
Our President and COO Kathryn Corzo talks with editor Brian Buntz from Drug Discovery & Development.
Our CEO Mark Kotter talks to Drug Discovery World about different approaches to synthetic biology and its applications in drug dis...